IPHA welcomes the addition of a new vaccine to the childhood immunisation programme and calls for greater dialogue between the State and vaccines companies

03/12/2010




 

The Irish Pharmaceutical Healthcare Association (IPHA) welcomes the announcement this morning by the Health Service Executive (HSE) that it has added an enhanced pneumococcal vaccine (PCV) to the childhood immunisation programme.

The addition of this new vaccine to the childhood immunisation programme means that Irish children are now less likely to get the life-threatening illness, meningitis. Irish children are now protected against a total of 12 infectious agents under the current national vaccination programme.


Report shows that there are 100 new medicines in development to treat and prevent HIV/AIDS and related conditions

03/12/2010




Research-based pharmaceutical research companies are working on 100 new medicines and vaccines to treat and prevent HIV/AIDS and related conditions, according to a new report published today to mark World Aids Day.

Although scientists have made phenomenal advances in understanding the disease and have discovered 31 approved medicines used to control the virus in different ways, there is still no cure and no vaccine to prevent transmission. Moreover, the virus has proved its capacity to mutate and become resistant to available treatments, resulting in a constant...


Page 1 | 2